CVS 2011 Annual Report Download - page 16

Download and view the complete annual report

Please find page 16 of the 2011 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 84

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84

CVS CAREMARK 14 2011 ANNUAL REPORT
Specialty medicines treat serious diseases such as cancer, multiple sclerosis, and hemophilia. By
utilizing our integrated assets, we’re helping clients control costs while also improving the specialty
patient experience. For example, many specialty patients have the option of picking up their mail
order prescriptions at our retail pharmacy stores.
CVS Caremark has been a leader in this business since its inception more than 30 years ago. The
fastest-growing segment of our industry, specialty is expected to generate $15 billion in revenue for
the company in 2012. We provide specialty patients with a seamless experience from initial intake
through dispensing and adherence management, including access to expert clinical pharmacists. This
is critical because frequent side effects can cause patients to fall off therapy without ongoing support
from medical professionals.
Our Specialty Guideline Management program has long helped identify inappropriate utilization, in
some cases reducing a client’s specialty spend by more than five percent in a given year. In 2012, we
are introducing programs to manage the portion of specialty drugs that are administered by physicians
and billed directly to payors. Greater focus on this area could yield savings for our clients in the range
of 15 to 20 percent.
S P E C I A LT Y P H A R M A C Y:
Unlike the typical PBM, we serve specialty patients through
multiple touch points that include our specialty mail pharmacies
as well as CVS/pharmacy
® and our retail specialty pharmacy
locations. It is just one of our many integration “sweet spots.”
Siloed
THE INDUSTRY WAY:
Integrated